STERIS plc STE
208.93
0.16
0.08%
as of 25 Sep
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
STERIS plc (STE) Shares outstanding
STERIS plc's shares outstanding at the end of fiscal 2026 was $98.7M, unchanged from fiscal 2025. At the end of the quarter to 30 June 2026 it was $97.9M. Over the past ten years it has ranged from $60.0M (fiscal 2015) to $100.2M (fiscal 2023); the current reading is higher than 75% of that period. STERIS plc ranks 32nd of 147 Medical Devices companies by shares outstanding.
Shares outstanding, annual
Annual
| Period | Shares outstanding | Change |
|---|---|---|
| FY2026 | $98.7M | (0.40%) |
| FY2025 | $99.1M | (0.30%) |
| FY2024 | $99.4M | (0.84%) |
| FY2023 | $100.2M | 1.95% |
| FY2022 | $98.3M | 14.47% |
| FY2021 | $85.9M | 0.30% |
| FY2020 | $85.6M | 0.20% |
| FY2019 | $85.5M | (0.29%) |
| FY2018 | $85.7M | (0.44%) |
| FY2017 | $86.1M | 20.95% |
Quarterly
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $97.9M | (0.81%) |
| Mar 2026 | $98.7M | 0.10% |
| Dec 2025 | $98.6M | (0.20%) |
| Sep 2025 | $98.8M | 0.00% |
| 42 more quarters | Free account |
Against its own ten years
Low $60.0M
High $100.2M
Ten-year median
$86.0M
Current reading's percentile
75
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| PHG Koninklijke Philips N.V. compare | $968.6M |
| GEHC GE HealthCare Technologies Inc. compare | $454.0M |
| SNN Smith & Nephew SNATS, Inc. compare | $449.4M |
| DXCM DexCom, Inc. compare | $390.1M |
| ZBH Zimmer Biomet Holdings, Inc. compare | $192.8M |
| STE STERIS plc | $97.9M |
| PEN Penumbra, Inc. compare | $39.6M |
| BIO Bio-Rad Laboratories, Inc. compare | $26.8M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $26.8M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- The full statement